Outcomes in locally recurrent rectal cancer treated with reirradiation stereotactic ablative radiotherapy (SABR)

被引:0
|
作者
Muirhead, R. [1 ]
Aitken, K. [2 ]
Holmes, J. [3 ]
Harrison, M. [4 ]
Harji, D. [5 ]
O'Cathail, S. [6 ]
Taylor, C. [7 ]
Wing, M. [8 ]
机构
[1] Oxford Univ Hosp NHS Fdn Trust, Dept Oncol, Oxford, England
[2] Royal Marsden Hosp, Dept Oncol, Fulham Rd, London, England
[3] Univ Oxford, Ctr Stat Med, Oxford, England
[4] Mt Vernon Hosp, Mt Vernon Canc Treatment, Northwood, Middx, England
[5] Univ Leeds, Dept Colorectal Surg, Leeds, W Yorkshire, England
[6] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland
[7] St Marks Hosp, Dept Colorectal Surg, London, England
[8] Bowel Canc UK, Patient Representat, London, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO-1262
引用
收藏
页码:S1041 / S1042
页数:2
相关论文
共 50 条
  • [1] Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors
    Trakul, Nicholas
    Harris, Jeremy P.
    Le, Quynh-Thu
    Hara, Wendy Y.
    Maxim, Peter G.
    Loo, Billy W., Jr.
    Diehn, Maximilian
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : 1462 - 1465
  • [2] Stereotactic Body Radiation Therapy Reirradiation for Locally Recurrent Rectal Cancer: Outcomes and Toxicity
    Smith, Thomas
    O'Cathail, Sean M.
    Silverman, Sabrina
    Robinson, Maxwell
    Tsang, Yatman
    Harrison, Mark
    Hawkins, Maria A.
    [J]. ADVANCES IN RADIATION ONCOLOGY, 2020, 5 (06) : 1311 - 1319
  • [3] Reirradiation with Stereotactic Ablative Radiotherapy in Recurrent Nasopharyngeal Carcinoma
    Yilmaz, Melek Tugce
    Yigit, Ecem
    Kahvecioglu, Alper
    Yedekci, Fazli Yagiz
    Sari, Sezin Yuce
    Cengiz, Mustafa
    Ozyigit, Gokhan
    Gullu, Ibrahim
    Aksoy, Sercan
    Yazici, Gozde
    [J]. RADIOTHERAPY AND ONCOLOGY, 2024, 192 : S90 - S92
  • [4] Stereotactic reirradiation for locally recurrent prostate cancer after definitive radiotherapy
    Francolini, G.
    Cerbai, C.
    Carnevale, M. G.
    Di Cataldo, V.
    Detti, B.
    Loi, M.
    Frosini, G.
    Guerrieri, B.
    Morelli, I.
    Roghi, M.
    Ganovelli, M.
    Allegra, A.
    Salvestrini, V.
    Visani, L.
    Olmetto, E.
    Greto, D.
    Simontacchi, G.
    Mangoni, M.
    Desideri, I.
    Meattini, I.
    Livi, L.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S457 - S457
  • [5] FRACTIONATED STEREOTACTIC RADIOTHERAPY AS REIRRADIATION FOR LOCALLY RECURRENT HEAD AND NECK CANCER
    Roh, Kwang-Won
    Jang, Ji-Sun
    Kim, Min-Sik
    Sun, Dong-Il
    Kim, Bum-Soo
    Jung, So-Lyoung
    Kang, Jin-Hyoung
    Yoo, Eun-Jung
    Yoon, Sei-Chul
    Jang, Hong-Seok
    Chung, Su-Mi
    Kim, Yeon-Sil
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (05): : 1348 - 1355
  • [6] Reirradiation With Stereotactic Ablative Radiotherapy In Recurrent Head And Neck Cancers
    Yigit, Ecem
    Yilmaz, Melek Tugce
    Kahvecioglu, Alper
    Yedekci, Fazli Yagiz
    Sari, Sezin Yuce
    Cengiz, Mustafa
    Ozyigit, Gokhan
    Gullu, Ibrahim
    Aksoy, Sercan
    Yazici, Gozde
    [J]. RADIOTHERAPY AND ONCOLOGY, 2024, 192 : S92 - S94
  • [7] Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer
    Desai, Neil B.
    Laine, Aaron M.
    Timmerman, Robert D.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1070):
  • [8] Potential for Isotoxic Re-irradiation Stereotactic Ablative Body Radiotherapy in Locally Recurrent Rectal Cancer
    Robinson, M.
    OCathail, S.
    Duffton, A.
    Aitken, K.
    Muirhead, R.
    [J]. CLINICAL ONCOLOGY, 2022, 34 (09) : 571 - 577
  • [9] The Future of Stereotactic Ablative Radiotherapy (SABR)
    Loo, B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S283 - S284
  • [10] Prognostic role of texture analysis in lung cancer treated with stereotactic ablative radiotherapy (SABR)
    Nardone, V.
    Tini, P.
    Mazzoni, L. N.
    La Penna, A.
    Biondi, M.
    Sebaste, L.
    Carfagno, T.
    Vanzi, E.
    De Otto, G.
    Battaglia, G.
    Pastina, P.
    Carbone, S. F.
    Buonamici, F. Banci
    Pirtoli, L.
    [J]. ANNALS OF ONCOLOGY, 2016, 27